BOHD
4-methyl-2,5-dimethoxy-beta-hydroxyphenethylamine.png
BOHD-3d-sticks.png
Names
Preferred IUPAC name
2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethan-1-ol
Other names
4-Methyl-2,5-dimethoxy-beta-hydroxyphenethylamine
2-(4-Methyl-2,5-dimethoxyphenyl)ethan-beta-hydroxyamine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C11H17NO3/c1-7-4-11(15-3)8(9(13)6-12)5-10(7)14-2/h4-5,9,13H,6,12H2,1-3H3 checkY
    Key: WCURBUJUIMRCCJ-UHFFFAOYSA-N checkY
  • InChI=1/C11H17NO3/c1-7-4-11(15-3)8(9(13)6-12)5-10(7)14-2/h4-5,9,13H,6,12H2,1-3H3
    Key: WCURBUJUIMRCCJ-UHFFFAOYAU
  • COc1cc(C)c(cc1C(O)CN)OC
Properties
C11H17NO3
Molar mass 211.261 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

BOHD (4-methyl-2,5-dimethoxy-beta-hydroxyphenethylamine) is a lesser-known psychedelic drug. It is the beta-hydroxy derivative of 2C-D. BOHD was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 50 mg, and the duration unknown.[1] BOHD produces a marked drop in blood pressure.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of BOHD.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also

References

  1. ^ a b Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
  2. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.